drugset / Trial / NCT00280605
ALF-ONE : ALFuzosin ONcE Daily
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of the study is to collect, under daily practice conditions, clinical data on the safety profile and the efficacy of a new formulation of alfuzosin administered once daily in patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
Timeline
- Start
- 2005-08
- Primary completion
- 2006-02
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alfuzosin | Small molecule | 10 mg | — |